The Board of Governors is chaired by Professor Leonard Kritharides and comprises nominees from The Sydney Local Health District, the Deans of Medical Schools and The University of Sydney, leading corporate executives, together with the Director of Cardiovascular Research of the Heart Research Institute.

The Board is responsible for the governance of the Institute. It approves and monitors budgets and scientific progress. The majority of the Board positions are available to be filled via election by the members of the incorporated company, the Heart Research Institute Ltd, to represent the corporate and scientific community.

The Board comprises:

Professor Leonard Kritharides


Len Kritharides is Head of Department and Director of Cardiology at Concord Repatriation General Hospital (CRGH) Sydney, Professor of Medicine at The University of Sydney, Head of the Atherosclerosis Research Laboratory Group at the ANZAC Research Institute and Deputy Clinical Director of the Cardiovascular Stream of the Sydney Local Health District. In 1994 Len completed a PhD in macrophage biology at the Heart Research Institute (HRI). After postdoctoral research at the HRI and in the USA, he took up an appointment as Staff Specialist in Cardiology at Concord Hospital in 1998 and became Head of Department in 2003. He was awarded a NSW Government Community Services Award for his contribution to Concord Repatriation General Hospital in 2006, the President’s Medal for contributions to the Cardiac Society of Australia and New Zealand in 2013, and Distinguished Researcher Award by the Australian Vascular Biology Society in 2014. He is currently Chair of the Cardiovascular Health and Advisory Committee of the National Heart Foundation and Chairs the Specialist Training Committee in Cardiology of the Royal Australian College of Physicians. He is Chairman of the Heart Research Institute.

Dr Teresa Anderson


Teresa Anderson is Chief Executive of the Sydney Local Health District (SLHD) and is responsible for the strategic and operational management of SLHD. SLHD has the following services and hospitals: Royal Prince Alfred Hospital, (Australia’s premier quaternary and tertiary hospital), Concord Hospital (a leading tertiary hospital), Canterbury and Balmain Hospitals, Sydney Dental Hospital, Community Health, Mental Health, Drug Health and Population Health services. Board appointments include IPAA NSW Council, Centenary Institute, Ingham Health Research Institute, Heart Research Institute, Central and Eastern Sydney PHN (primary health network), ANZAC Research Institute, Australian Institute of Health Service Management, Centre for Primary Health Care and Equity and HealthShare NSW (MoH).

Mr John Batistich


John Batistich is an Advisor to a range of technology start-ups and has more than 24 years of experience in research, marketing, digital innovation and general management with blue chip companies. Marketing communications led by John have won a Cannes Lion Award and an Australian Advertising Effectiveness Award. He has been a member of the Australian Market and Social Research Society Client Advisory Board and the Australian Research Awards judging panel. John holds a Masters in Management degree from Macquarie Graduate School of Management majoring in Human Resources, a Bachelor of Business degree from the University of Western Sydney majoring in Marketing and a Certificate in Digital Marketing from the Association for Data-driven Marketing and Advertising.

Mrs Sandra (Sandie) Boswell


Sandra Boswell has over 20 years of experience in the field of R&D Incentives and Government programs centred on innovation. Between 2008 and 2013, Sandra led the PwC Australia R&D team with a strong focus on marketing strategies to increase revenue. This role allowed her to build a business and develop marketing strategies that were relevant to various industries and clients in the market ranging from institutional targets to traditional Australian small and medium-sized enterprises (SMEs). Sandra is a strong advocate for national innovation and R&D. She has been an active participant in contributing to the national debate on innovation and R&D policy at the Federal Government level and continually deals with the regulators and Government about the policy including Government and Opposition Members of Parliament and Senators from the crossbench. She influences debate and has worked with the Government in drafting and setting up the current R&D Incentive program. She believes innovation is vital to a healthy, robust economy and has been active in the national debate around the critical role that Government plays in attracting and retaining innovation in Australia. She regularly utilises social and mainstream media to contribute to the public debate about the role of innovation in the economy and has had media experience over several years commenting on these issues. Sandra is a founding member of the National Reference Group, a peak body which provides industry-relevant feedback and insights to Government on the operation of the R&D Tax Incentive Program. In this capacity she has also been involved in a number of Government related innovation think tanks. She regularly liaises with all policy stakeholders on tax reform relating to innovation. Sandra has a multi sector experience and governance experience gained on various PwC internal boards. She has a good insight into the PwC clients’ corporate level governance regimes.

Professor Andrew Boyle


Andrew Boyle is currently Professor of Cardiovascular Medicine, Clinical Dean of the Hunter Clinical School of the University of Newcastle and a practising Interventional Cardiologist. He has over 100 career journal publications, eight book chapters and three patents. Andrew heads both a clinical and a basic science research team. He started studying left ventricular remodelling as the subject of his PhD (2002-5) and has continued in this field ever since. He has considerable experience in rodent models, porcine models and human clinical trials. While his laboratory continues to study in vitro and preclinical models of cardiac fibrosis, LV remodeling and cardiac regeneration, he is also international PI on a clinical trial of a novel drug for post-infarction LV remodeling, conducted at over 15 sites world-wide. His clinical research focuses on acute coronary syndromes, including novel risk stratification parameters and optimizing treatment strategies especially in rural and remote locations.

Mr Barry Brownjohn


Barry Brownjohn is an experienced banking and finance executive with skill sets including capital markets, risk management, corporate advisory and business planning. Senior executive roles have included capital markets and investment banking businesses in Asia, North America and in Australia serving as Managing Director of Bank of America. Utilising his deep industry experience and understanding of the use of technology in financial services he has served as an advisor to incumbent industry participants and new businesses seeking to bring innovative business models and enabling technologies to the market. Non-executive Director roles have included for Citigroup Pty Ltd, Dexus Property Group, Bakers Delight Holdings Pty Limited and The South Australian Financing Authority. Barry has a Bachelor degree in Accounting Finance and Systems from the University of New South Wales.

Mr Rod Halstead

LLB (Syd) (LLM) (Lon) FAICD

Rod Halstead is an alumni of the University of Sydney, where he graduated with a Bachelor of Laws and was subsequently awarded a degree of Master of Laws by the University of London. He is a Fellow of the Australian Institute of Company Directors. Rod has practised as a lawyer based in Sydney and has been a Partner in leading Australian law firms for in excess of 40 years. During this time he has practised extensively in corporate law, mergers and acquisitions, and corporate governance. Rod has served as director of public companies whose securities are listed on the Australian Securities Exchange and as Chair of private investment companies. He has held the position of Honorary Solicitor for The Heart Research Institute since its formation and was elected a Governor at the Annual General Meeting in May 2017.

Professor Shaun Jackson


Shaun Jackson is an NHMRC Senior Principal Research Fellow (SPRF) and faculty member at the prestigious Scripps Research Institute in La Jolla, San Diego (CA, USA). Shaun was a co-founder of the Australian Centre for Blood Diseases in Melbourne and a founder of Kinacia, an Australian biotechnology company developing novel diagnostic and therapeutic products aimed at preventing blood clotting. He is currently Director of Cardiovascular Research at the Heart Research Institute and Charles Perkins Centre, as well as Research Director of Atherothrombosis Services within the Department of Cardiology at the Royal Prince Alfred Hospital (RPA). Shaun’s research interests are focussed in the area of atherothrombosis and cardiovascular disease. Shaun established his independent research laboratory in the Monash Department of Medicine at Box Hill Hospital (1998-2003). In 2004 he moved to the Alfred Medical Research and Education Precinct (AMREP), where he co-founded and became Research Director of the Australian Centre for Blood Diseases (ACBD).

Mr Richard Rassi

Richard Rassi is a chartered accountant having spent most of his career working at Deloitte and as a partner in the firm up to December 2011. He now operates a consulting practice (Riclin Consulting) providing consulting services in the areas of strategy, governance, risk management, audit and financial reporting. Richard also mentors a number of senior professionals and executives. He continues to be retained by Deloitte to assist with the delivery of services to clients including providing a quality assurance role on a range of audit and advisory engagements. Complimenting this expertise are various governance roles including as director and audit committee chair of various retail superannuation boards operating within National Australia Bank (August 2012 to May 2014) and as a member of the audit and finance committee for the Australian Broadcasting Corporation (current appointment). He also currently serves as a member of the Disciplinary Tribunal of Chartered Accountants Australia and New Zealand. Richard maintains an active involvement with the Australian Institute of Company Directors and has assisted the AICD with the development of their various director education programs. This has included authoring a course on strengthening financial governance and delivering webinars on year- end financial reporting obligations for directors and governance related topics. 

Ms Cath Rogers


Cath Rogers has held several global finance and technology focused roles including with a successful software venture in London, Accenture strategy consulting in Sydney, ABN AMRO corporate finance in Sydney, and Credit Suisse investment banking in Sydney, New York and Latin America. Cath has also worked with the International Finance Corporation, part of the World Bank Group in Washington DC, Masdar Capital, a sovereign wealth fund in Abu Dhabi, Anchorage Capital Partners in Sydney and AirTree Ventures, a Sydney-based venture capital fund focused on digital and software investments. Cath is the co-founder of a technology venture called the Digital Receipt Exchange. In addition to the HRI, Cath is a Non-Executive Director of ASX Listed McGrath Real Estate and not-for-profit Heads Over Heels, which supports women entrepreneurs. Cath holds a Bachelor of Commerce majoring in Finance from the University of New South Wales and Master of Business Administration from INSEAD in France. She is a Chartered Financial Analyst and a Graduate of the Australian Institute of Company Directors.

Professor Stephen Simpson


Stephen Simpson is Academic Director of the Charles Perkins Centre, a University of Sydney cross-faculty initiative aimed at researching and implementing cross-disciplinary approaches to alleviating the burden of obesity, diabetes, cardiovascular disease and related conditions, and is the Executive Director of Obesity Australia. Stephen was born in Melbourne and grew up in Australia. After completing his undergraduate degree at the University of Queensland, he undertook his PhD at the University of London. Stephen spent 22 years at the University of Oxford, first in Experimental Psychology, then in the Department of Zoology and the Oxford University Museum of Natural History, before returning to Australia in 2005 as an Australian Research Council Federation Fellow, then ARC Laureate Fellow. Stephen, with close colleague David Raubenheimer, developed an integrative modelling framework for nutrition (the Geometric Framework), which was devised and tested using insects. This has since been applied to a wide range of organisms, from slime moulds to humans, and problems, from aquaculture and conservation biology to the dietary causes of human obesity and ageing. He has also revolutionised understanding of swarming in locusts, with research spanning neurochemical events within the brains of individual locusts to continental-scale mass migration. In 2007 Stephen was elected a Fellow of the Australian Academy of Science, in 2013 was elected a Fellow of the Royal Society of London as “one of the world’s foremost entomologists and nutritional biologists”, and in 2015 was made a Companion of the Order of Australia “for eminent service to biological and biomedical science.”